Technical Report No. 73-2: Application of Medical Device Regulation Annex 1 Requirements for Staked Needle Syringes
Premium Members: to claim your annual free technical document download, email membership@pda.org and indicate the document you wish to claim.
- Format
- PDF Single User
- Member Price
- $180.00
- Nonmember Price
- $325.00
- Government Price
- $180.00
Please sign in or become a member to purchase items from the PDA bookstore.
PDA Technical Report No. 73-2: Application of Medical Device Regulations, Annex I Requirements for Staked Needle Syringes represents the current state of knowledge as to the application of European Union Regulation (EU) 2017/745 on medical devices (MDR).
Since this regulatory requirement is new, expectations of the Notified Body and competent authorities may diverge as the process evolves. As an addendum to PDA Technical Report No. 73: Prefilled Syringe User Requirements for Biotechnology Applications, this technical report provides recommendations on preparing the required documentation of the device part of the PFS to facilitate obtaining an opinion.
This technical report systematically recommends the amount and depth of information needed for each relevant GSPR to support pharmaceutical companies in assembling the submission file to the NBs and provides information on documents that provide guidance on completing the NB submission file.
The device part, including its corresponding componentsandmaterials, are in scope as they will be evaluated by the NBs, but the medicinal product (drug) is not.
Table of Contents
1.0. Introduction
2.0. Glossary and Abbreviations
3.0. Regulatory Background
4.0. Content of Submission file to notified bodies
5.0. Applicable GSPRS and Supportive Documents
6.0. References
About the Authors
Fabrizio Bacelle, Stevanato Group
Bettine Boltres, PhD, West Pharmaceutical Services
Alfred Breunig, Nipro PharmaPackaging International
Rakhi Dalal, PhD., U.S. Food and Drug Administration
Wendy Durand, PharmD, Aptar Pharma
Andreas Emmendoerffer, MD, PhD, F. Hoffmann-La Roche Ltd.
Stephanie Goebel, Novartis
Elly Gysels, PhD, Sensile Medical AG
Tibor Hlobik, West Pharmaceutical Services Inc.
Vikas Jaitely, PhD, Merck Group
Ankica Jakovljevic, PharmD, Stevanato Group
Mayk Kresse, PhD, Bayer Pharma AG
Andrea Salmaso, PharmD, Stevanato Group
Tabassam Sharif, Datwyler Pharma Packaging
Gabriele Widerstein, Boehringer Ingelheim
Urs Widmer, confinis AG
Daniele Zuccato, SCHOTT Pharma
Chris Hurlstone, Team Consulting Ltd.
Mark Di Cioccio, Team Consulting Ltd.
Alastair Willoughby, Team Consulting Ltd.
Larry Wallman, Genentech
Desmon Dizon, Genentech
Christoph Joosten, PhD, F. Hoffmann-La Roche Ltd.
Stephanie Horn, PhD, F. Hoffmann-La Roche Ltd.
Federica Rusmini, Janssen Vaccines & Prevention B.V.
Tilman Roedle and Associates., Vetter Pharma